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post-tests, changes were observed only at exercise groups. In running
group, signiﬁcant increase (P=0.049) occurred immediately after the
walking exercise. Also in swimming group COMP serum concentration
increased signiﬁcantly (P = 0.084) immediately after the walking exercise.
Signiﬁcant decrease (P=0.051) of serum COMP concentration were
observed at direct impact running group at 30-minutes recovery after
walking exercise.
Conclusions: In this age group, moderate walking activity can have
little inﬂuence on the increase serum COMP concentrations. However,
signiﬁcant decrease of serum COMP concentration after walking exercise
observed only in running group. This change, after 12-weeks regular
weight-bearing impact exercise, will be explained with the functional
adaptation of articular cartilage to speciﬁc environmental requirements.
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Purpose: Calcium phosphate crystals such as basic calcium phosphate
(BCP) and calcium pyrophosphate dihydrate (CPPD) are known to occur
in intra-articular synovial ﬂuid (SF) and may be associated with a number
of destructive arthropathies. For instance, BCP crystals are found in up to
70% of osteoarthritic joints and current data suggests that BCP crystals
represent a potential therapeutic target. Previous studies have used
enzymatic and chemical methods to reduce organic contamination in the
biological sample in an attempt to facilitate crystal detection. However, by
doing so, valuable information from other biomarkers in SF sample will
be lost. Bisphosphonates are commonly used as pharmaceutical drugs
for the treatment of osteoporosis and are known to bind very speciﬁcally
and strongly to the surface of calcium phosphate. We have exploited this
chemical speciﬁcity to create an extraction platform which can isolate
calcium phosphate crystals from SF samples in a simple and selective
manner.
Methods: Spiked samples were prepared by suspending synthetic cal-
cium phosphate crystals (HA/CPPD) in artiﬁcial SF (3% hyaluronan in
human serum) at concentrations normally found in vivo. SF samples
were aspirated from the affected joints (mainly knees and shoulders)
of patients with OA and/or other arthropathies. Commercially available
superparamagnetic beads (Dynal) were derivatised with bisphosphonates
(neridronate) using carbodiimide coupling chemistry. Bisphosphonate-
modiﬁed superparamagnetic beads (BPSM beads) were mixed and incu-
bated with the SF samples for one hour. Removal of unwanted biological
material and washing was achieved by using a small permanent magnet
to pull the beads to the side of the vessel. Scanning electron microscopy
(SEM) and energy dispersive x-ray (EDX) spectroscopy (Hitachi SN-3000)
was used to conﬁrm the presence/absence of crystals captured by the
beads. Calcium content was measured using an o-cresolpthalein com-
plexone assay on a Biotek Powerwave XS 96-well reader. Raman spectra
were collected on a Renishaw InVia Raman microscope (514/785 nm
laser excitation).
Results: SEM/EDX measurements of spiked SF showed that HA/CPPD
crystals were successfully isolated by the BPSM beads. Typically, high
levels of calcium measured using colorimetry were consistent with the
presence of crystals in the sample as found in SEM. Raman spectral
features indicated that there are certain marker bands that are speciﬁc
to the type of crystal species present, such as the speciﬁc signature
modes at 960 cm−1 (BCP) and 1043 cm−1 (CPPD). Hence, Raman mi-
crospectroscopy provides a means of detecting the type of crystal present
following the initial separation step.
Conclusions: In this approach, the surface of superparamagnetic poly-
mer beads was modiﬁed with commercially available bisphosphonates,
essentially providing the beads with the capability to capture calcium
phosphate crystals from SF samples. Once isolated, the crystals were
successfully detected and characterised using colorimetry, scanning elec-
tron microscopy and Raman microspectroscopy. The main challenge is
to correlate the high levels of calcium with the presence of crystals and
the proposed diagnosis. This aspect will require the analysis of a larger
pool of samples and may provide a tool for improved diagnosis and
characterisation of OA and other crystal related pathologies.
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Purpose: Synovial ﬂuid examination is a valuable but under-utilised diag-
nostic tool for arthritis. The link between basic calcium phosphate (BCP)
crystals in synovial ﬂuid (SF) and osteoarthritis (OA) is well described.
BCP crystals are unique OA and may serve as a biomarker and aid to
more accurate diagnosis of the disease. The detection and quantiﬁcation
of BCP crystals in OA is particularly difﬁcult due to their submicron
dimensions and the challenges of ﬁnding them within the complex and
viscous synovial ﬂuid matrix. A further complication resides in the ability
to distinguish them from the other calcium-containing crystals that can co-
exist in synovial ﬂuid such as calcium pyrophosphate dihydrate (CPPD),
commonly associated with pseudogout. The aim of our work is to develop
semi-quantitative, colorimetric assays for detecting calcium phosphate
crystals in SF.
Methods: Model SF samples were prepared by suspending synthetic
hydroxyapatite (HA) and CPPD crystals in simulated SF (3% hyaluronan
in human serum) at concentrations normally found in vivo. Patient SF
samples were aspirated from the affected joints (mainly knees and
shoulders) of 20 people with OA and/or other arthropathies. For crystal
extraction, SF samples (100ml) were ﬁrst treated with sodium hypochlorite
and ultrasonicated to break down the organic matrix. Samples were then
centrifuged to pellet the crystals. This was followed by a number of
washing steps with water. The pellet was dissolved in 1N nitric acid to
dissociate the crystals into their constituent ions. Calcium concentration
was measured using an o-cresolpthalein complexone assay (1−10mg/l
range). Phosphate concentration was measured using a modiﬁed molyb-
date blue method (1−50mg/l) on a Biotek Powerwave XS 96-well reader
and also determined using a vanadate-molybdate reagent with 0.002M
solution of malachite green (MG) as a chromophore. Values obtained
for the samples were normalised against analytical grade calcium and
phosphate standards. Scanning electron microscopy (SEM) and energy
dispersive x-ray (EDX) spectroscopy (Hitachi SN-3000) were used to
conﬁrm the presence/absence of crystals isolated within the pellet.
Results: Sodium hypochlorite solution was found to be an effective
deproteinising agent that helps to degrade the organic material but
does not break down HA and CPPD crystals due to their stability in
basic solution. SEM of spiked SF showed that HA/CPPD crystals were
successfully isolated from the organic matrix with no signs of degradation.
Calcium levels found in patient SF samples ranged from 40–200 (mg/l).
The presence of BCP or CPPD could be diagnosed using the Ca:P ratio.
The ratio closer to 1:1 indicated excess of CPPD and closer to 1:1 –
excess of HA crystals. Typically, high levels of calcium and phosphate
levels were consistent with the presence of crystals in the sample as
found in SEM.
Conclusions: We present a simple, semi-quantitative method for detect-
ing calcium phosphate crystals in SF. The main challenge is to correlate
the high levels of calcium/phosphate with the presence of crystals and
the proposed diagnosis. This aspect will require the analysis of a larger
pool of samples and may provide a tool for improved diagnosis and char-
acterisation of OA and other crystal related pathologies. The MG method
is suitable for naked-eye categorising of SF samples for high/medium/low
phosphates content.
